Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma

Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma
复制标题

唾液管癌组织病理学指标的预后意义

DOI:
10.1097/pas.0000000000001413
复制
发表时间:
2020
期刊:
The American Journal of Surgical Pathology
影响因子:
--
通讯作者:
Nagao Toshitaka et al.
Nagao Toshitaka et al.
中科院分区:
--
文献类型:
--
作者:
Nakaguro Masato;Sato Yukiko;Tada Yuichiro;Kawakita Daisuke;Nagao Toshitaka et al.

文献摘要

相似文献

涎腺导管癌是一种罕见的侵袭性恶性肿瘤,组织学上类似于高级别乳腺导管癌。由于这种疾病的罕见性,证实组织学特征与患者生存之间关系的数据有限。我们对151例SDC病例进行了全面的组织学回顾,并分析了各种组织学参数与临床结果之间的关系,目的是建立一个预测SDC患者预后的组织学风险分层模型。多因素分析显示,突出的核多形性(总生存期[OS]: P= 0.013;无进展生存期[PFS]: P= 0.019)、≥30个有丝分裂/10个HPF (PFS: P= 0.013)、高肿瘤出芽(OS: P= 0.011; PFS: P< 0.001)和高低分化簇(OS: P< 0.001; PFS: P< 0.001)是独立的预后因素。在多变量分析中,血管侵犯患者与较短的PFS有轻微的显著相关(P= 0.064)。我们提出了一个3层的组织学风险分层模型,该模型基于4个预后相关参数(突出的核多形性、≥30个有丝分裂/10个HPF、血管侵犯和高低分化簇)中阳性因素的总数。低危(0 ~ 1分)(23%)、中危(2 ~ 3分)(54%)、高危(4分)(23%)肿瘤患者的OS和PFS依次进行性恶化(风险比分别为2.13、2.28、4.99、4.50,P趋势< 0.001)。我们的组织学风险分层模型可以有效地预测患者的生存,并可能有助于指导与SDC患者管理相关的临床决策。
Salivary duct carcinoma (SDC) is a rare, aggressive malignancy that histologically resembles high-grade mammary duct carcinoma. Because of the rarity of this entity, data verifying the association between histologic features and patient survival are limited. We conducted a comprehensive histologic review of 151 SDC cases and performed an analysis of the association between various histomorphologic parameters and the clinical outcome with the aim of developing a histologic risk stratification model that predicts the prognosis of SDC patients. A multivariate analysis revealed that prominent nuclear pleomorphism (overall survival [OS]: P= 0.013; progression-free survival [PFS]: P= 0.019),≥ 30 mitoses/10 HPF (PFS: P= 0.013), high tumor budding (OS: P= 0.011; PFS: P< 0.001), and high poorly differentiated clusters (OS: P< 0.001; PFS: P< 0.001) were independent prognostic factors. Patients with vascular invasion demonstrated a marginally significant association with shorter PFS (P= 0.064) in a multivariate analysis. We proposed a 3-tier histologic risk stratification model based on the total number of positive factors among 4 prognostically relevant parameters (prominent nuclear pleomorphism,≥ 30 mitoses/10 HPF, vascular invasion, and high poorly differentiated clusters). The OS and PFS of patients with low-risk (0 to 1 point)(23% of cases), intermediate-risk (2 to 3 points)(54% of cases), and high-risk (4 points)(23% of cases) tumors progressively deteriorated in this order (hazard ratio, 2.13 and 2.28, and 4.99 and 4.50, respectively; P trend< 0.001). Our histologic risk stratification model could effectively predict patient survival and may be a useful aid to guide clinical decision-making in relation to the management of patients with SDC.